Wei-Chen Lin, MD, PhD

  • 11Articles
  • 72KReads
  • 2017–2025Active
  • 24Collaborators
  • 264Citations

About

Wei-Chen Lin, MD, PhD, is affiliated with the Department of Psychiatry at Taipei Veterans General Hospital and the College of Medicine at National Yang Ming Chiao Tung University in Taipei, Taiwan. Lin has contributed to 11 articles published between 2017 and 2025 on topics including child and adolescent psychiatry, depression, suicide, Alzheimer disease, bipolar disorder, neurodevelopmental disorders, and neurology. Frequent collaborators include Mu-Hong Chen, Ya-Mei Bai, Cheng-Ta Li, Shih-Jen Tsai, and Tung-Ping Su.

Publications

JCP
Appetite Hormone Regulation Biotypes of Major Affective Disorders
Original Research

Appetite Hormone Regulation Biotypes of Major Affective Disorders

April 9, 2025

Three appetite hormone regulation biotypes were identified among patients with major affective disorders. They were associated with proinflammatory cytokine profiles and executive function, with one biotype group showing poorer...
, , , et al
JCP
Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts
Original Research

Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts

July 8, 2024

A single infusion of low-dose ketamine resulted in a brief (~4 hour) yet significant reduction in hopelessness.
, , , et al
JCP
Excess Mortality Associated With Schizophrenia
Original Research

Excess Mortality Associated With Schizophrenia

September 13, 2023

Females, patients with connective tissue disorders, and those aged 20 years or younger were especially impacted by the effect of schizophrenia on increasing mortality.
, , , et al
JCP
Original Research

OCD and Dementia Risk

May 11, 2021

Case reports suggest a link between obsessive-compulsive disorder (OCD) and dementia, but this association has received little research. The current study investigated dementia risk among OCD patients using a...
, , , et al
JCP
Original Research

Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response

November 10, 2020

Can we determine which patients will respond to ketamine just by observing their mood during the infusion? This study evaluated antidepressant outcomes with ketamine in 71 patients, focusing on ...
, , , et al
JCP
Original Research

Prenatal Acetaminophen Exposure and ADHD Risk

September 10, 2019

Should a pregnant woman take acetaminophen? Learn the specific trimesters when consumption places the child most at risk for later being diagnosed with ADHD and whether other factors, like...
, , , et al
JCP
Article

Bipolar Disorder and Sexually Transmitted Infection

March 12, 2019

What are some risk factors for (and protective factors against) sexually transmitted infections among adolescents and young adults with bipolar disorder?
, , , et al
JCP
Original Research

Type 2 Diabetes in Youths With SGA Exposure

March 5, 2019

Do kids who take second-generation antipsychotics have the same risk of developing type 2 diabetes as adults taking these drugs? In this longitudinal follow-up study of over 91,000 adolescents...
, , , et al
JCP
Original Research

ADHD and Type 2 Diabetes Mellitus

May 1, 2018

Anecdotal evidence suggests that risk factors related to type 2 diabetes mellitus—including obesity, hypertension, and dyslipidemia—may be associated with attention-deficit/hyperactivity disorder. This study looked at this possible relationship more...
, , , et al
JCP
Original Research

Repeated Infections and MDD Risk

December 19, 2017

Up to 50% of patients with systemic inflammation from ongoing physical illness develop major depressive disorder. This nationwide, population-based study in 2 independent cohorts explored the relationship between inflammation...
, , , et al
JCP
Original Research

Autism Spectrum Disorder and Suicide Attempts

August 29, 2017

Autism has been linked to higher rates of depression and to suicidality. This study leveraged data from a large insurance database to find out whether the presence of depression...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe